Welcome to our dedicated page for Aesthetic Medical International Holdings Group Ltd. SEC filings (Ticker: AIH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aesthetic Medical International Holdings Group Ltd. filings document foreign-issuer disclosures for an ADS issuer whose securities trade on OTCQX under PAIYY. Form 6-K current reports present unaudited interim financial results for its China aesthetic medical services business, including revenue, gross profit, selling, general and administrative expenses, treatment activity and management commentary on operating initiatives.
The filings also identify the company as a Form 20-F filer and provide formal records tied to its public reporting status, ADR/ADS disclosures and operating performance across surgical aesthetic, non-surgical aesthetic, general medical and other aesthetic services.
Aesthetic Medical International reported operational shifts in the first half of 2025: total treatment cases fell by 2.3% year‑on‑year following reduced advertising spend, while the mix moved toward non‑surgical aesthetic procedures, which rose by 3.6 percentage points as a share of total treatments. Average spending per customer declined 1.2%, from RMB1,099 to RMB1,086, driven by increased promotional activity such as discounted live‑stream e‑commerce offers. The disclosure includes references to standard financial line items and balance sheet headings but lacks complete numeric tables or full financial results in the provided extract.